Vertex gearing up for launch as sickle cell therapy review advances

Vertex gearing up for launch as sickle cell therapy review advances

Source: 
BioPharma Dive
snippet: 

Executives at the biotech say they’re trying to get ahead of the payer and production challenges that will face their exa-cel therapy, which is made through an exhaustive and expensive process.